3 Stocks Estimated To Be Up To 49.3% Below Their Intrinsic Value

As the U.S. stock market grapples with volatility driven by fluctuating trade policies and economic uncertainties, investors are increasingly on the lookout for opportunities in undervalued stocks. In this environment, identifying stocks that are trading below their intrinsic value can present a compelling opportunity for those looking to capitalize on potential market mispricings.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Brookline Bancorp (NasdaqGS:BRKL)	$11.08	$21.98	49.6%
Atour Lifestyle Holdings (NasdaqGS:ATAT)	$30.59	$60.31	49.3%
Dime Community Bancshares (NasdaqGS:DCOM)	$28.74	$56.26	48.9%
Gilead Sciences (NasdaqGS:GILD)	$116.04	$229.16	49.4%
Brunswick (NYSE:BC)	$58.75	$114.71	48.8%
Live Oak Bancshares (NYSE:LOB)	$29.55	$58.73	49.7%
Five9 (NasdaqGM:FIVN)	$32.89	$65.55	49.8%
JBT Marel (NYSE:JBTM)	$131.07	$260.21	49.6%
Albemarle (NYSE:ALB)	$76.48	$150.46	49.2%
TransMedics Group (NasdaqGM:TMDX)	$65.29	$129.23	49.5%

Click here to see the full list of 194 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

Vertex (NasdaqGM:VERX)

Overview: Vertex, Inc. offers enterprise tax technology solutions for retail, wholesale, and manufacturing sectors both in the United States and internationally, with a market cap of approximately $5.39 billion.

Operations: The company's revenue primarily comes from its Software & Programming segment, which generated $666.78 million.

Estimated Discount To Fair Value: 19.4%

Vertex, Inc. is trading at US$34.06, below its estimated fair value of US$42.24, suggesting it might be undervalued based on discounted cash flows. Despite reporting a net loss of US$52.73 million for 2024, Vertex forecasts revenue growth to outpace the broader U.S. market at 12.6% annually and anticipates profitability within three years with a high forecasted return on equity of 47.7%.

• Our growth report here indicates Vertex may be poised for an improving outlook.
• Click to explore a detailed breakdown of our findings in Vertex's balance sheet health report.

Atour Lifestyle Holdings (NasdaqGS:ATAT)

Overview: Atour Lifestyle Holdings Limited, with a market cap of approximately $4.26 billion, develops lifestyle brands centered around hotel offerings in the People's Republic of China through its subsidiaries.

Operations: The company's revenue segment is primarily derived from Atour Group, which generated CN¥6.67 billion.

Estimated Discount To Fair Value: 49.3%

Atour Lifestyle Holdings, trading at US$30.59, is significantly undervalued with an estimated fair value of US$60.31 based on discounted cash flows. The company anticipates revenue growth of 22.8% per year, surpassing the U.S. market average of 8.5%, and earnings growth at 25.65% annually over the next three years, exceeding market expectations of 14%. Its return on equity is projected to reach a very high level in three years' time at 45.4%.

• In light of our recent growth report, it seems possible that Atour Lifestyle Holdings' financial performance will exceed current levels.
• Click here to discover the nuances of Atour Lifestyle Holdings with our detailed financial health report.

RXO (NYSE:RXO)

Overview: RXO, Inc. operates a truck brokerage business across the United States, Canada, Mexico, Asia, and Europe with a market capitalization of approximately $3.34 billion.

Operations: The company generates revenue primarily through its Transportation - Trucking segment, amounting to $4.55 billion.

Estimated Discount To Fair Value: 34.7%

RXO, Inc. is trading at US$20.43, significantly undervalued with a fair value estimate of US$31.30 based on discounted cash flows. Despite recent shareholder dilution and a net loss of US$20 million in Q4 2024, RXO's revenue growth forecast of 17.7% annually surpasses the U.S. market average of 8.5%. The company is expected to become profitable within three years, although its future return on equity remains modest at 8.3%.

• Our earnings growth report unveils the potential for significant increases in RXO's future results.
• Click here and access our complete balance sheet health report to understand the dynamics of RXO.

Taking Advantage

• Access the full spectrum of 194 Undervalued US Stocks Based On Cash Flows by clicking on this link.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com